Logo image of OB

OUTBRAIN INC (OB) Stock Fundamental Analysis

NASDAQ:OB - Nasdaq - US69002R1032 - Common Stock - Currency: USD

3.83  +0.03 (+0.79%)

After market: 4.02 +0.19 (+4.96%)

Fundamental Rating

5

OB gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 70 industry peers in the Interactive Media & Services industry. While OB seems to be doing ok healthwise, there are quite some concerns on its profitability. OB is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

OB had positive earnings in the past year.
In the past year OB had a positive cash flow from operations.
In multiple years OB reported negative net income over the last 5 years.
Each year in the past 5 years OB had a positive operating cash flow.
OB Yearly Net Income VS EBIT VS OCF VS FCFOB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

The Return On Assets of OB (-0.13%) is comparable to the rest of the industry.
The Return On Equity of OB (-0.31%) is better than 61.43% of its industry peers.
Industry RankSector Rank
ROA -0.13%
ROE -0.31%
ROIC N/A
ROA(3y)-0.58%
ROA(5y)0.02%
ROE(3y)-2.34%
ROE(5y)-0.13%
ROIC(3y)N/A
ROIC(5y)N/A
OB Yearly ROA, ROE, ROICOB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

OB has a Gross Margin of 21.59%. This is amonst the worse of the industry: OB underperforms 80.00% of its industry peers.
In the last couple of years the Gross Margin of OB has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for OB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y0.91%
OB Yearly Profit, Operating, Gross MarginsOB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 5 10 15 20

More info and screens

6

2. Health

2.1 Basic Checks

OB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OB has been increased compared to 1 year ago.
OB has less shares outstanding than it did 5 years ago.
OB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
OB Yearly Shares OutstandingOB Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
OB Yearly Total Debt VS Total AssetsOB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

OB has an Altman-Z score of 1.91. This is not the best score and indicates that OB is in the grey zone with still only limited risk for bankruptcy at the moment.
OB has a better Altman-Z score (1.91) than 61.43% of its industry peers.
There is no outstanding debt for OB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.91
ROIC/WACCN/A
WACC9.09%
OB Yearly LT Debt VS Equity VS FCFOB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 1.19 indicates that OB should not have too much problems paying its short term obligations.
OB's Current ratio of 1.19 is on the low side compared to the rest of the industry. OB is outperformed by 70.00% of its industry peers.
OB has a Quick Ratio of 1.19. This is a normal value and indicates that OB is financially healthy and should not expect problems in meeting its short term obligations.
OB has a Quick ratio of 1.19. This is in the lower half of the industry: OB underperforms 70.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 1.19
OB Yearly Current Assets VS Current LiabilitesOB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 157.14% over the past year.
OB shows a decrease in Revenue. In the last year, the revenue decreased by -4.91%.
Measured over the past years, OB shows a small growth in Revenue. The Revenue has been growing by 5.30% on average per year.
EPS 1Y (TTM)157.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-22.22%
Revenue 1Y (TTM)-4.91%
Revenue growth 3Y-4.31%
Revenue growth 5Y5.3%
Sales Q2Q%-5.5%

3.2 Future

Based on estimates for the next years, OB will show a very strong growth in Earnings Per Share. The EPS will grow by 171.36% on average per year.
The Revenue is expected to grow by 20.24% on average over the next years. This is a very strong growth
EPS Next Y1105.1%
EPS Next 2Y383.14%
EPS Next 3Y171.36%
EPS Next 5YN/A
Revenue Next Year60.63%
Revenue Next 2Y30.62%
Revenue Next 3Y20.24%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
OB Yearly Revenue VS EstimatesOB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
OB Yearly EPS VS EstimatesOB Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6 0.8

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 95.75, the valuation of OB can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of OB is on the same level as its industry peers.
OB's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.79.
With a Price/Forward Earnings ratio of 7.95, the valuation of OB can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of OB indicates a rather cheap valuation: OB is cheaper than 92.86% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.38. OB is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 95.75
Fwd PE 7.95
OB Price Earnings VS Forward Price EarningsOB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

OB's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. OB is cheaper than 67.14% of the companies in the same industry.
88.57% of the companies in the same industry are more expensive than OB, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.02
EV/EBITDA 17.05
OB Per share dataOB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

OB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as OB's earnings are expected to grow with 171.36% in the coming years.
PEG (NY)0.09
PEG (5Y)N/A
EPS Next 2Y383.14%
EPS Next 3Y171.36%

More info and screens

0

5. Dividend

5.1 Amount

OB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OUTBRAIN INC

NASDAQ:OB (4/25/2025, 8:00:01 PM)

After market: 4.02 +0.19 (+4.96%)

3.83

+0.03 (+0.79%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)02-27 2025-02-27/bmo
Earnings (Next)05-08 2025-05-08
Inst Owners28.22%
Inst Owner Change-0.22%
Ins Owners4.83%
Ins Owner Change0.15%
Market Cap359.79M
Analysts78.46
Price Target6.46 (68.67%)
Short Float %3.2%
Short Ratio2.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)133.61%
Min EPS beat(2)-17.62%
Max EPS beat(2)284.85%
EPS beat(4)3
Avg EPS beat(4)81.7%
Min EPS beat(4)-17.62%
Max EPS beat(4)284.85%
EPS beat(8)6
Avg EPS beat(8)532.56%
EPS beat(12)8
Avg EPS beat(12)323.45%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.62%
Min Revenue beat(2)-8.54%
Max Revenue beat(2)-4.69%
Revenue beat(4)0
Avg Revenue beat(4)-6.75%
Min Revenue beat(4)-9.09%
Max Revenue beat(4)-4.67%
Revenue beat(8)1
Avg Revenue beat(8)-5.66%
Revenue beat(12)3
Avg Revenue beat(12)-3.21%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-22.8%
PT rev (3m)-5.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-77.31%
EPS NY rev (1m)0%
EPS NY rev (3m)187.12%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)19.57%
Revenue NY rev (1m)28.85%
Revenue NY rev (3m)46.67%
Valuation
Industry RankSector Rank
PE 95.75
Fwd PE 7.95
P/S 0.4
P/FCF 7.02
P/OCF 5.25
P/B 1.56
P/tB 2.38
EV/EBITDA 17.05
EPS(TTM)0.04
EY1.04%
EPS(NY)0.48
Fwd EY12.59%
FCF(TTM)0.55
FCFY14.25%
OCF(TTM)0.73
OCFY19.06%
SpS9.47
BVpS2.46
TBVpS1.61
PEG (NY)0.09
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.13%
ROE -0.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.59%
FCFM 5.76%
ROA(3y)-0.58%
ROA(5y)0.02%
ROE(3y)-2.34%
ROE(5y)-0.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y0.91%
F-Score6
Asset Turnover1.62
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 88.78%
Cap/Sales 1.94%
Interest Coverage N/A
Cash Conversion 1002.21%
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 1.19
Altman-Z 1.91
F-Score6
WACC9.09%
ROIC/WACCN/A
Cap/Depr(3y)94.29%
Cap/Depr(5y)88.52%
Cap/Sales(3y)2.24%
Cap/Sales(5y)2.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)157.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-22.22%
EPS Next Y1105.1%
EPS Next 2Y383.14%
EPS Next 3Y171.36%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.91%
Revenue growth 3Y-4.31%
Revenue growth 5Y5.3%
Sales Q2Q%-5.5%
Revenue Next Year60.63%
Revenue Next 2Y30.62%
Revenue Next 3Y20.24%
Revenue Next 5YN/A
EBIT growth 1Y-45.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3709.71%
EBIT Next 3Y272.19%
EBIT Next 5YN/A
FCF growth 1Y890.2%
FCF growth 3Y11.78%
FCF growth 5Y51.85%
OCF growth 1Y398.77%
OCF growth 3Y6.5%
OCF growth 5Y32.58%